pcDNA3.1-hAsCpf1(TATV) (pY220) Citations (3)
Originally described in: Engineered Cpf1 variants with altered PAM specificities.Gao L, Cox DBT, Yan WX, Manteiga JC, Schneider MW, Yamano T, Nishimasu H, Nureki O, Crosetto N, Zhang F Nat Biotechnol. 2017 Jun 5. doi: 10.1038/nbt.3900. PubMed Journal
Articles Citing pcDNA3.1-hAsCpf1(TATV) (pY220)
| Articles |
|---|
Mb- and FnCpf1 nucleases are active in mammalian cells: activities and PAM preferences of four wild-type Cpf1 nucleases and of their altered PAM specificity variants.
Toth E, Czene BC, Kulcsar PI, Krausz SL, Talas A, Nyeste A, Varga E, Huszar K, Weinhardt N, Ligeti Z, Borsy AE, Fodor E, Welker E.
Nucleic Acids Res. 2018 Sep 20. pii: 5103950. doi: 10.1093/nar/gky815.
PubMed
Associated Plasmids |
| Direct control of lysosomal catabolic activity by mTORC1 through regulation of V-ATPase assembly. Ratto E, Chowdhury SR, Siefert NS, Schneider M, Wittmann M, Helm D, Palm W. Nat Commun. 2022 Aug 17;13(1):4848. doi: 10.1038/s41467-022-32515-6. PubMed |
| Dynamic quality control machinery that operates across compartmental borders mediates the degradation of mammalian nuclear membrane proteins. Tsai PL, Cameron CJF, Forni MF, Wasko RR, Naughton BS, Horsley V, Gerstein MB, Schlieker C. Cell Rep. 2022 Nov 22;41(8):111675. doi: 10.1016/j.celrep.2022.111675. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.